A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Mise à jour : Il y a 4 ans
Référence : NCT01525550

Femme et Homme

Extrait

The purpose of this study is to confirm the safety and efficacy of sunitinib in subjects with unresectable pancreatic neuroendocrine tumors.


Critère d'inclusion

  • Well-differentiated Pancreatic Neuroendocrine Tumor


Liens